1. KD Tripathi MD. Drugs acting on central nervous system. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page – 416.
2. Roger J. porter and Michael A. Rogawski. Anti-seizure drugs. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 417.
3. Hua Geng and Chengzhong Wang. Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials: Neuropsyhiatric disease and treatment, 2017; [Accessed Oct 16, 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342615/
4. Porters RJ, Meldrum BS. Anti-seizure Drugs. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 406-407.
5. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 1037-1038.
6. Sanofi-Synthelabo (India) Private Ltd. April 2017, [Accessed Oct 16, 2020] https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/Vinlep_Susp_PI.pdf?la=en
7. Novartis Pharmaceuticals Corporation. 2005, U.S. Food & Drug Administration; [Accessed Oct 16, 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021014s013lbl.pdf